Mesirow Institutional Investment Management’s Merit Medical Systems MMSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$11M Buy
113,438
+689
+0.6% +$68.7K 0.84% 69
2024
Q3
$11.1M Sell
112,749
-6,464
-5% -$591K 0.85% 70
2024
Q2
$10.2M Sell
119,213
-11,574
-9% -$910K 0.9% 65
2024
Q1
$9.91M Sell
130,787
-3,229
-2% -$249K 0.88% 65
2023
Q4
$10.2M Buy
134,016
+12,971
+11% +$905K 0.95% 64
2023
Q3
$8.35M Buy
121,045
+29,324
+32% +$2.11M 0.85% 69
2023
Q2
$7.67M Sell
91,721
-5,961
-6% -$485K 0.79% 72
2023
Q1
$7.22M Sell
97,682
-22,840
-19% -$1.6M 0.78% 65
2022
Q4
$8.51M Sell
120,522
-31,355
-21% -$2.09M 1.12% 44
2022
Q3
$8.58M Buy
+151,877
New +$8.75M 1.24% 29

Other funds holding MMSI

Mesirow Institutional Investment Management's MMSI Position: Q4 2024 in Review

Mesirow Institutional Investment Management increased its Merit Medical Systems (MMSI) stake by 0.61% in Q4 2024, buying an estimated $68.7K and bringing the position to 113,438 shares worth $11M. The position accounts for 0.84% of the portfolio, ranked #69.

Mesirow Institutional Investment Management first reported a position in MMSI in Q3 2022 and has held it in 10 quarters since. The position peaked at $11.1M in Q3 2024. 385 funds tracked by Wall St. Rank hold MMSI as of Q4 2024.

  • Mesirow Institutional Investment Management held 113,438 shares of Merit Medical Systems worth $11M as of Q4 2024.
  • Mesirow Institutional Investment Management bought 689 Merit Medical Systems shares in Q4 2024, an estimated $68.7K.
  • Merit Medical Systems made up 0.84% of Mesirow Institutional Investment Management's portfolio in Q4 2024, its #69 holding.
  • Mesirow Institutional Investment Management first reported a position in Merit Medical Systems in Q3 2022 and has held it in 10 quarters since.
  • Mesirow Institutional Investment Management's Merit Medical Systems position peaked at $11.1M in Q3 2024.
  • 385 funds tracked by Wall St. Rank held Merit Medical Systems as of Q4 2024.

Based on Mesirow Institutional Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.